← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cytodel, Inc.
New York, NY
$934,229
Total funding
3
Grants
Funding over time
peak $433.7K · FY2014–23$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$934,229 · 3
By mechanism
R43$710,289 · 2
R41$223,940 · 1
Investigators at Cytodel, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of B8C1ad as an Orphan Drug for Iatrogenic Botulism$295,365
R43 · FY2023 · NS
Recombinant botulinum toxin with improved safety and effectiveness for treatment of dystonia$276,617
R43 · FY2022 · NS
Recombinant Botulinum Neurotoxin for Treatment of Spastic Disorders$223,940
R41 · FY2014 · NS
Recombinant botulinum toxin with improved safety and effectiveness for treatment of dystonia$138,307
R43 · FY2023 · NS